Online Availability of Diamond Shruumz Before and After FDA Recall Initiation: Qualitative Assessment and Simulated Test Purchasing
- PMID: 40586741
- PMCID: PMC12232493
- DOI: 10.2196/64820
Online Availability of Diamond Shruumz Before and After FDA Recall Initiation: Qualitative Assessment and Simulated Test Purchasing
Abstract
Background: Reports of hospitalization associated with Diamond Shruumz-branded mushroom-containing products in October 2024 led to a manufacturer's recall that restricted the sale, distribution, and accessibility of this new and emerging psychoactive product.
Objective: This study seeks to assess the continuing online availability of a mushroom-containing edible product in a diverse e-commerce landscape, specifically aiming to identify and characterize its online availability before and after recall initiation.
Methods: A retrospective online market surveillance of Diamond Shruumz products using structured and automated search queries was employed to identify online product marketing and availability. Online surveillance included the monitoring of multiple social media platforms, cannabis e-commerce websites, and search engine queries between June 22 and June 27, 2024, immediately preceding the manufacturer-initiated recall. Post-recall simulated purchases were then conducted on July 12, 2024, on platforms, websites and domains identified as continuing to actively market and sell the products through online product listings.
Results: Prior to product recall, a total of 4117 product listings across 1600 (38.86%) social media posts and user-generated comments, 11 (0.27%) cannabis e-commerce websites, and 2509 (60.94%) hyperlinks from internet search queries were generated for further content analysis. Review of online sources revealed 49 social media posts, 8 e-commerce shops, and 67 domains that were identified as actively marketing and selling products prior to recall. Post-recall, we identified 45 (67.16%) remaining domains that continued to market the product from these different online sources. Simulated purchases revealed that 15 (33.33%) domains successfully transacted test purchases and 30 (66.66%) transactions failed because of account verification or payment failure.
Conclusions: The Diamond Shruumz recall exemplifies the ongoing challenge of unknown consumer harm associated with new and emerging substances marketed and sold on the internet, which is especially concerning as these products appeal to younger audiences with a variety of edible flavored products. While a recall was initiated and products became unavailable, our study found that post-recall online vendors continued to market and sell the products. This indicates that there are ongoing challenges to effectuate recalls and online enforcement in a diverse e-commerce landscape that can rapidly bring new and novel psychoactive substances to the market.
Keywords: e-commerce; psychoactive product; market; online monitoring; online surveillance; psychedelics; qualitative assessment; recall; social media; website.
© Tim Mackey, Matthew Nali, Meng Zhen Larsen, Zhuoran Li, Jiawei Li, Joshua Yang. Originally published in the Journal of Medical Internet Research (https://www.jmir.org).
Conflict of interest statement
Figures
Similar articles
-
Assessing Characteristics and Compliance of Online Delta-8 Tetrahydrocannabinol Product Sellers.Cannabis Cannabinoid Res. 2024 Aug;9(4):e1132-e1141. doi: 10.1089/can.2022.0341. Epub 2023 May 17. Cannabis Cannabinoid Res. 2024. PMID: 37200462
-
Nutritional labelling for healthier food or non-alcoholic drink purchasing and consumption.Cochrane Database Syst Rev. 2018 Feb 27;2(2):CD009315. doi: 10.1002/14651858.CD009315.pub2. Cochrane Database Syst Rev. 2018. PMID: 29482264 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Tobacco packaging design for reducing tobacco use.Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD011244. doi: 10.1002/14651858.CD011244.pub2. Cochrane Database Syst Rev. 2017. PMID: 28447363 Free PMC article.
-
Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury.Cochrane Database Syst Rev. 2016 Jul 1;7(7):CD011020. doi: 10.1002/14651858.CD011020.pub2. Cochrane Database Syst Rev. 2016. PMID: 27364851 Free PMC article.
References
-
- Severe illness potentially associated with consuming Diamond ShruumzTM brand chocolate bars, cones, and gummies. US Centers for Disease Control and Prevention. [15-07-2024]. https://www.cdc.gov/environmental-health-studies/outbreak-investigation-... URL. Accessed.
-
- Investigation of illnesses: Diamond Shruumz-brand chocolate bars, cones, & gummies (June 2024) US Food and Drug Administration. [15-07-2024]. https://www.fda.gov/food/outbreaks-foodborne-illness/investigation-illne... URL. Accessed.
-
- 21 US Code § 813 - treatment of controlled substance analogues. Cornell Law School. [15-07-2024]. https://www.law.cornell.edu/uscode/text/21/813 URL. Accessed.
-
- DEA Diversion Control Division; Dec, 2022. [15-07-2024]. N,N-Dimethyltryptamine (DMT)https://deadiversion.usdoj.gov/drug_chem_info/dmt.pdf URL. Accessed.
-
- Michienzi A, Hamlin J, Farah R, Bazydlo L. Notes from the field: Schedule I substances identified in nootropic gummies containing Amanita muscaria or other mushrooms - Charlottesville, Virginia, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Jul 18;73(28):628–630. doi: 10.15585/mmwr.mm7328a3. doi. Medline. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous